A federal judge ordered a Johnson & Johnson unit on Friday to pay the U.S. government $1.64 billion after a jury found it liable in a whistleblower lawsuit for illegally promoting the HIV drugs ...

A Careerminds survey of over 3,000 workers has identified New Jersey's most coveted employer based on its attractive benefits ...

Johnson & Johnson (JNJ) stock trades flat as the firm starts pharma earnings season with strong Q1 results and raised sales ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 ...

Known as the home of big-name companies including Johnson & Johnson, New Jersey has become a destination for more and more ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

JNJ's pharma segment offsets MedTech softness as the company kicks off Big Pharma earnings with raised guidance ...

Johnson & Johnson expects full-year earnings in the range of $10.50 to $10.70 per share, with revenue in the range of $91 billion to $91.8 billion. This story was generated by Automated Insights ( ...

Johnson & Johnson shares dipped slightly today on first-quarter results and an update on the impact of tariffs.

Johnson & Johnson is a holding company ... in 1887 and is headquartered in New Brunswick, NJ.